STOCK TITAN

Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Perrigo (NYSE: PRGO) has announced it will release its third quarter 2024 financial results on November 6, 2024. The company will host a conference call at 8:30 A.M. (EST) on the same day. The earnings call will be accessible via webcast through Perrigo's investor relations website and by phone. A replay of the call will be available from approximately 12:00 P.M. (EST) on November 6 until midnight November 13, 2024.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PRGO

-1.67%
1 alert
-1.67% News Effect

On the day this news was published, PRGO declined 1.67%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DUBLIN, Oct. 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2024 financial results on Wednesday, November 6, 2024, and host a conference call beginning at 8:30 A.M. (EST).

The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 96443. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday, November 6, until midnight Wednesday, November 13, 2024. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 96443#.

About Perrigo 

Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Litigation Securities Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2023.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373 / bradley.joseph@perrigo.com

Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238 / nicholas.gallagher@perrigo.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-release-third-quarter-2024-financial-results-on-november-6-2024-302284520.html

SOURCE Perrigo Company plc

FAQ

When will Perrigo (PRGO) release Q3 2024 earnings?

Perrigo will release its third quarter 2024 financial results on Wednesday, November 6, 2024.

What time is Perrigo's (PRGO) Q3 2024 earnings call?

Perrigo's Q3 2024 earnings conference call will begin at 8:30 A.M. (EST) on November 6, 2024.

How can I access Perrigo's (PRGO) Q3 2024 earnings call?

The earnings call can be accessed via webcast at Perrigo's investor relations website or by phone at 800-836-8184 (International: 646-357-8785) using ID #96443.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

2.05B
137.02M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2